Q&A

Biopharma Resilience: Mass Immunization Programs

Source: Cytiva
Aurélia Nguyen, Chief Programme Strategy Officer for Gavi, the Vaccine Alliance
Aurélia Nguyen, Chief Programme Strategy Officer for Gavi, the Vaccine Alliance

Hear from Aurélia Nguyen, Chief Programme Strategy Officer at Gavi, the Vaccine Alliance, to better understand the factors driving successful vaccination initiatives and to examine the impact of COVID-19 on collaboration across the biopharmaceutical industry. Explore the challenges involved with mass immunization programs, what role government can play in facilitating vaccination programs, how technology is transforming the biopharma industry, and more.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cytiva